|Articles|September 22, 2022
COVID-19 Agent Molnupiravir
Author(s)YMC Europe GmbH
Molnupiravir, which is a prodrug, and its active agent β-d-N4-hydroxycytidine can be separated by using a YMC-Triart C18 UHPLC column and a MS-compatible mobile phase.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Waters Completes Combination with BD Biosciences and Diagnostic Solutions Businesses
2
A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?
3
LC–MS Determination of PFAS Distribution in Porcine Tissues for Food Safety Monitoring
4
Chromatography-Based Metabolomic Insights for Safer Kimchi Fermentation
5